Medicinal – Page 121

Identification of Challenging Dermatophyte Species Using Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry

mycolabadmin

This study shows that a specialized technique called MALDI-TOF mass spectrometry can accurately identify fungal skin infections by analyzing protein patterns. Researchers created a customized library of local fungal species that, when combined with commercial databases, improved identification accuracy from 16% to 91%. This advancement helps doctors quickly identify the exact type of fungal infection patients have, enabling faster and more appropriate treatment decisions.

Morpho-phylogenetic evidence reveals novel hyphomycetous fungi on medicinal plants in Southwestern China

mycolabadmin

Researchers discovered and described 12 new species of fungi found on medicinal plants in southwestern China. By examining the fungi’s appearance under microscopes and analyzing their DNA, scientists confirmed these were previously unknown species. Some of these fungi may produce beneficial compounds while others produce toxins, highlighting the importance of understanding which fungi live on medicinal plants to ensure their quality and safety for human use.

Transcriptome and Metabolome Integration Reveals the Impact of Fungal Elicitors on Triterpene Accumulation in Sanghuangporus sanghuang

mycolabadmin

Researchers studied how special fungal compounds called elicitors can boost the production of healing substances in a medicinal mushroom called Sanghuangporus sanghuang. By analyzing genes and metabolites, they found that adding elicitors increased beneficial compounds like betulinic acid and 2-hydroxyoleanolic acid by up to 114-fold. These findings suggest a practical way to produce more medicinal compounds from this mushroom for health applications.

Clinical aspects and recent advances in fungal diseases impacting human health

mycolabadmin

Fungal infections are becoming a major health threat, affecting over a billion people worldwide. The main problems are difficulty diagnosing these infections, increasing resistance to current medications, and limited treatment options. Doctors and the public need better awareness, and new antifungal drugs with different approaches are needed to effectively treat resistant infections.

Diagnostic performance of Aspergillus-specific immunoglobulin G immunochromatographic and enzyme-linked immunosorbent assay testing in chronic pulmonary aspergillosis: comparative analysis across subtypes and influencing factors

mycolabadmin

Chronic pulmonary aspergillosis is a serious fungal lung infection that often develops after tuberculosis. This study compared two blood tests for diagnosing this disease: a quick point-of-care test and a traditional lab test. The quick test performed better overall and could be used in areas without advanced laboratory equipment, though previous antifungal or steroid medications can reduce its effectiveness.

Conjugation of a Cryptococcus neoformans-derived metalloprotease to antifungal-loaded PLGA nanoparticles treats neural cryptococcosis in an in vitro model

mycolabadmin

Researchers developed special nanoparticles that can cross the protective barrier surrounding the brain by using a protein from a fungal infection. These nanoparticles are loaded with an antifungal drug and can effectively treat cryptococcal brain infections in laboratory tests. This approach offers a new way to deliver medicines to the brain without invasive procedures, potentially helping patients with serious brain infections that are currently difficult to treat.

A Review on Aspergillosis in Turkey: As a Main Fungal Disease in Poultry

mycolabadmin

Aspergillosis is a serious fungal disease affecting turkeys, especially young birds, caused by breathing in fungal spores from moldy hay, compost or poorly ventilated housing. The disease causes respiratory problems, can spread to other organs, and can kill 30-50% of affected flocks. Prevention through good ventilation, clean housing and dry feed is more effective than treatment since few antifungal drugs are approved for food animals. Understanding how environmental conditions promote this disease is key to protecting turkey populations.

Disseminated mucormycosis leading to a fatal gastrointestinal perforation in a pediatric case of EBV-associated Hemophagocytic lymphohistiocytosis

mycolabadmin

A 12-month-old girl developed a serious immune system disorder called hemophagocytic lymphohistiocytosis triggered by Epstein-Barr virus infection. Despite aggressive treatment, she developed a life-threatening fungal infection caused by mucormycosis that spread throughout her digestive system. The case illustrates how fungal infections can rapidly progress and become fatal in children with severely weakened immune systems, emphasizing the need for doctors to recognize early warning signs like tissue darkening on the skin.

Exploring the health benefits of Ganoderma: antimicrobial properties and mechanisms of action

mycolabadmin

Ganoderma is a medicinal mushroom that has been used in traditional medicine for thousands of years and shows promise as a natural antibiotic. The mushroom contains special compounds like polysaccharides and triterpenoids that can kill harmful bacteria and fungi by damaging their cell walls and boosting your immune system. Recent research shows it works against common infections like those caused by staph bacteria and E. coli, and may even help fight antibiotic-resistant germs.

Giant Hydatid Cyst Originating From Psoas Muscle Extending to the Iliac Bone: A Case Report

mycolabadmin

A 50-year-old man from southwestern Iran developed a large parasitic cyst in his psoas muscle caused by tapeworm infection. After imaging confirmed the diagnosis, doctors removed the cyst surgically and treated him with antiparasitic medication. The patient recovered well with no complications during the following year.

Research Topic: Medicinal